Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: "infusion center"

Zenobillis / shutterstock.com

In the Wake of Hurricanes Helene & Milton: Lessons Learned

Susan Bernstein  |  October 4, 2024

Editor’s note: As states prepare for Hurricane Milton, at least 223 people have died and hundreds are still unaccounted for in the destruction wrought by Hurricane Helene on Sept. 26. North and South Carolina, as well as Tennessee, were hard hit, and the U.S. medical system is being tested. Headlines include: “Helene Nearly Turned a…

Filed under:EMRsFacilityPractice Support Tagged with:Disaster preparationNatural disaster

The Biosimilar Economic Conundrum: Where We Stand

Carina Stanton  |  January 17, 2024

Reimbursement has fallen below acquisition price for some biosimilar versions of infliximab, forcing practices and patients to make difficult decisions. The ACR is working to change this.

Filed under:InsuranceLegislation & Advocacy Tagged with:ACR advocacyACR Insurance Subcommittee (ISC)Biosimilars

The Voice of Rheumatology: The Most Important Rheumatology Coalition You’ve Never Heard Of

Joseph Cantrell, JD  |  July 25, 2023

The Voice of Rheumatology was established as an informal coalition to aid effective collaborations on issues important to the rheumatology community. The group has grown to become an integral mechanism for the exchange of information among groups including the ACR, Arthritis Foundation, Coalition of State Rheumatology Organizations (CSRO), Alliance for Women in Rheumatology and more to strengthen partnerships on a range of federal, state and regulatory issues.

Filed under:Legislation & AdvocacyProfessional Topics Tagged with:Advocacypartnership

Expert Guidance from the ACR/ARP Access in Rheumatology Meeting

Glen Rodman  |  July 12, 2023

ACR/ARP Access in Rheumatology—As part of ACR Education Exchange 2023, the ACR/ARP Access in Rheumatology meeting addressed some of the major challenges in coverage and payment that U.S. rheumatology practices face. Speakers included rheumatologists, rheumatology professionals, office managers and CEOs. The first section, Thriving, Not Just Surviving—Keeping Your Rheumatology Practice Solvent, focused on financial management…

Filed under:Meeting ReportsPractice Management Tagged with:Access to careACR Education Exchange 2023financespatient carePractice ManagementTreatment

Expert Guidance from the ACR/ARP Access in Rheumatology Meeting

Glen Rodman  |  June 20, 2023

Speakers addressed major challenges in coverage and payment facing rheumatology practices, including financial management and obstacles to patient access to treatment.

Filed under:Meeting ReportsPractice Support Tagged with:Access in Rheumatologyfinancial planninghealthcare access

The 2022 ACR Masters

Patrice Fusillo  |  December 8, 2022

Recognition as an ACR Master is one of the highest honors the College bestows. The designation of Master is conferred on ACR members, age 65 or older by Oct. 1 of the year in which they are nominated, who have made outstanding contributions to the ACR and the field of rheumatology through scholarly achievement and/or…

Filed under:AwardsProfessional Topics Tagged with:Dr. Abraham “Avi” GedaliaDr. Alan KivitzDr. Andrew LasterDr. Anne DavidsonDr. Arvind ChopraDr. Asgar Ali KallaDr. Carlos D. RoseDr. Daniel AlbertDr. David A. CabralDr. Deh-Ming ChangDr. Ellen M. GravalleseDr. Frederick B. VivinoDr. H. Michael BelmontDr. Ken SchiklerDr. Larry W. MorelandDr. Leslie E. KahlDr. Linda BockenstedtDr. Maria C. CidDr. Max HamburgerDr. Munther A. KhamashtaDr. Nancy J. OlsenDr. Nina D. SchwartzDr. Richard BucalaDr. Robert A. S. RoubeyDr. Robert H. ShmerlingDr. Robert W. WarrenDr. Samina Hayat

A New President Takes the ACR Helm: Introducing Douglas White, MD, PhD

Leslie Mertz, PhD  |  November 17, 2022

In his new role as the 86th president of the ACR, Douglas White, MD, PhD, is excited about the opportunities to serve and energize the organization and members in the coming year.

Filed under:American College of RheumatologyPresident's PerspectiveProfiles Tagged with:ACR presidentDr. Douglas White

Ethics Forum: Has the Patient Asked for More Than Can Be Ethically Allowed?

Richard L. Allman, MD, MS, FACP, FACR  |  November 10, 2022

The patient, a 76-year-old woman, had very active polyarticular rheumatoid arthritis (RA), despite triple therapy with conventional synthetic disease-modifying anti-rheumatic drugs (DMARDs), low-dose corticosteroids and occasional intra-articular injections—the latter providing only transient symptomatic relief. She had elevated inflammatory markers and a 28-joint Disease Activity Score (DAS-28) score of 7.4.  Because of the severity of her…

Filed under:EthicsProfessional Topics Tagged with:Ethics ForumPrescription drugs

Zenobillis / shutterstock.com

Rheumatologists Share Lessons Learned in the Wake of Hurricane Ida

Susan Bernstein  |  July 13, 2022

Hurricane Ida intensified in the last two weeks of August 2021, battering the Cayman Islands and Cuba before hitting the Louisiana coast as a Category 4 storm just before Labor Day weekend.1 At landfall, Ida blasted southern Louisiana with maximum sustained winds of 150 knots, then turned in a north-northwestern direction to hit the New…

Filed under:EMRsFacilityPractice Support Tagged with:Disaster preparationNatural disaster

Higher Risk of Adverse Events When Biologic Infusions Are Done at Home

By Lisa Rapaport  |  June 15, 2021

(Reuters Health)—Patients who receive biologic infusions at home may have a higher risk of adverse events than those who receive the infusions at a health care facility, a new study suggests.1 Researchers examined administrative claims data on 57,220 adults who received a total of 752,150 biologic infusions for immune-mediated disease between 2007 and 2017. The…

Filed under:Biologics/DMARDsDrug Updates Tagged with:biologic infusionsBiologicshome infusion

  • 1
  • 2
  • 3
  • …
  • 6
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences